Changes of estimated glomerular filtration rates in healthy check-up adults with nonalcoholic fatty liver diseases
Sun Changgui, Zeng Jing,Sun Wanlu,et al.
Geriatric Hospital,Kunshan 215300,Jiangsu Province, China;Department of Gastroenterology,Center for Fatty Liver Disease Study,Xinhua Hospital,Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai 200092 China
[1] Levey AS,Bosch JP,Lewis JB,et al. A more accurate method to estimate glomerular filtration rate from serum creatinine:a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med,1999,130(6):461-470. [2] Singal AK,Salameh H,Kuo YF,et al. Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology. Transplantation,2014,98(2):216-221. [3] Allen AM,Kim WR,Therneau TM,et al. Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate. J Hepatol,2014,61(2):286-292. [4] Chang Y,Ryu S,Sung E,et al. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism,2008,57(4):569-576. [5] Ryu S,Chang Y,Kim DI,et al. Gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem,2007,53(1):71-77. [6] Targher G,Bertolini L,Rodella S,et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia,2008,51(3):444-450. [7] Johns BR,Pao AC,Kim SH. Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals. Nephrol Dial Transplant,2012,27(4):1410-1415. [8] Ferraro PM,Lupo A,Yabarek T,et al. Metabolic syndrome,cardiovascular disease,and risk for chronic kidney disease in an Italian cohort:analysis of the INCIPE study. Metab Syndr Relat Disord,2011,9(5):381-388. [9] Li G,Shi W,Hug H,et al. Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population. Biochem Med (Zagreb),2012,22(1):92-99. [10] 信丰智, 范建高. 欧洲非酒精性脂肪性肝病诊疗指南简介. 实用肝脏病杂志,2016,19(4):Ⅶ-Ⅷ. [11] 袁平戈. 瞬时弹性成像技术在肝病诊断中的应用进展. 实用肝脏病杂志,2016,19(1):4-7. [12] 沈峰,徐正婕,潘勤,等. FibroScan实施受控衰减参数评价脂肪肝的影响因素及重复性分析. 实用肝脏病杂志,2013,16(1):59-62. [13] 曾民德. 非酒精性脂肪性肝病:回顾历史,展望未来. 实用肝脏病杂志,2016,19(2):129-131.